1. Home
  2. ATNM vs NPT Comparison

ATNM vs NPT Comparison

Compare ATNM & NPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.01

Market Cap

33.9M

Sector

Health Care

ML Signal

HOLD

NPT

Texxon Holding Limited Ordinary shares

N/A

Current Price

$2.17

Market Cap

29.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
ATNM
NPT
Founded
2000
2011
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Specialty Chemicals
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
33.9M
29.7M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ATNM
NPT
Price
$1.01
$2.17
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$4.50
N/A
AVG Volume (30 Days)
105.6K
7.1M
Earning Date
05-06-2026
05-23-2026
Dividend Yield
N/A
N/A
EPS Growth
14.17
N/A
EPS
N/A
N/A
Revenue
$90,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.11
N/A
52 Week Low
$0.95
$1.14
52 Week High
$1.89
$22.38

Technical Indicators

Market Signals
Indicator
ATNM
NPT
Relative Strength Index (RSI) 36.37 49.91
Support Level $0.99 $1.19
Resistance Level $1.27 $6.15
Average True Range (ATR) 0.07 1.05
MACD -0.02 0.27
Stochastic Oscillator 0.10 9.31

Price Performance

Historical Comparison
ATNM
NPT

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.

About NPT Texxon Holding Limited Ordinary shares

Texxon Holding Ltd provides technology-enabled supply chain management services to customers in the plastics and chemical industries in East China. The company operates through two segments: Supply Chain Trading and Plastic Manufacturing. Its services include procurement, logistics, payments, and fulfillment for Chinese SMEs, and all revenue is generated from operations within the People's Republic of China.

Share on Social Networks: